New rules take effect April 1, including fewer barriers for doctors prescribing products, and available licenses for cultivators and manufacturers.
Lawmakers, regulators, and the courts are reshaping the industry, and the industry would like to be heard. But will the economy hold?
The legislature adjourned without a single hearing on a bill to legalize adult use cannabis. Its sponsor remains unfazed.
As the virus took hold, the outlets were closed. But when street dealers quickly moved in, the government began to rethink the situation.
In 2016, the US Drug Enforcement Administration said it would, for the first time, open applications for those hoping to become federally-licensed cannabis researchers. The details came four years later.
Amid the COVID-19 pandemic, a dilemma has hit the nascent industry: to close or not to close? We’re keeping track of how companies, and regulators, are reacting.
Cannabis Wire spoke with the CDC’s National Institute for Occupational Safety and Health about the emerging cannabis industry and its workers.
Three years plus after a successful legalization referendum, Maine is issuing its first conditional licenses and working out the final details.
The House Committee on Veterans Affairs voted in support of medical cannabis access and research, sending two bills to the full House.
Research from Penn State looks at Denver, Colorado and suggests that legalization is, at worst, neutral, but likely positive for hospitality.